Czech Republic - Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry
Since 2014, Czech Republic Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry jumped by 5.2% year on year. In 2019, the country was number 26 among other countries in Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry with $108,981,820.05 Million PPP. Czech Republic is overtaken by Finland, which was ranked number 25 at $174,819,523.26 Million PPP and is followed by Greece with $83,431,205.22 Million PPP. United States lead the ranking with $70,565,318,932.39 Million PPP in 2019, that is a growth of 3.3% versus 2018. China, Japan and Germany respectively ranked number 2, 3 and 4 in this ranking. Iceland recorded the best 5 years average growth at +43.9% per year, while Lithuania was the worst growing country at -42.6% per year.
Loading...
| Date | Million US Dollars PPP |
|---|---|
| 2019 | 108,981,820.05 |
| 2018 | 111,120,266.94 |
| 2017 | 89,924,363.32 |
| 2016 | 90,469,626.49 |
| 2015 | 86,915,059.96 |
How does Czech Republic rank in Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry?
| # | 69 Countries | Million US Dollars PPP | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
United States
|
70,565,318,932.39 | 2019 | +3.3 % | +4.5 % | View data | |
| 2 |
#2
China
|
13,956,388,273.35 | 2019 | +4.5 % | +6.1 % | View data | |
| 25 |
#25
Finland
|
174,819,523.26 | 2019 | +2.0 % | +3.3 % | View data | |
| 26 |
#26
Czech Republic
|
108,981,820.05 | 2019 | -1.9 % | +5.2 % | View data | |
| 27 |
#27
Greece
|
83,431,205.22 | 2019 | +0.1 % | +0.1 % | View data | |